Abstract | BACKGROUND: METHODS AND RESULTS: Rabbits were randomized to receive 5x10(11) total viral particles of Adv- betaARKct or PBS. After 5 days, hearts were arrested with University of Wisconsin solution, excised, and stored at 4 degrees C for 15 minutes or 4 hours before reperfusion on a Langendorff apparatus. Left ventricular (LV) function measured by end-diastolic pressure response to preload augmentation, contractility (LV dP/dt(max)), and relaxation (LV dP/dt(min)) was assessed by use of increasing doses of isoproterenol and compared with a control group of nonarrested hearts acutely perfused on the Langendorff apparatus. In the PBS-treated hearts, LV function decreased in a temporal manner and was significantly impaired compared with control hearts after 4 hours of cardioplegic arrest. LV function in Adv- betaARKct-treated hearts, however, was significantly enhanced compared with PBS treatment and was similar to control nonarrested hearts even after 4 hours of cardioplegia. Biochemically, several aspects of betaAR signaling were dysfunctional in PBS-treated hearts, whereas they were normalized in betaARKct-overexpressing hearts. CONCLUSIONS: Myocardial gene transfer of Adv- betaARKct stabilizes betaAR signaling and prevents LV dysfunction induced by prolonged cardioplegic arrest. Thus, betaARK1 inhibition may represent a novel target in limiting depressed ventricular function after CPB.
|
Authors | H T Tevaearai, A D Eckhart, K F Shotwell, K Wilson, W J Koch |
Journal | Circulation
(Circulation)
Vol. 104
Issue 17
Pg. 2069-74
(Oct 23 2001)
ISSN: 1524-4539 [Electronic] United States |
PMID | 11673348
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Peptide Fragments
- RNA, Messenger
- Recombinant Proteins
- Cyclic AMP-Dependent Protein Kinases
- BARKct protein, recombinant
- beta-Adrenergic Receptor Kinases
|
Topics |
- Adenoviridae
(genetics)
- Animals
- Cyclic AMP-Dependent Protein Kinases
(administration & dosage, antagonists & inhibitors, biosynthesis, genetics, metabolism)
- Gene Expression
- Genetic Therapy
(methods)
- Genetic Vectors
(administration & dosage, genetics)
- Heart Arrest, Induced
(adverse effects)
- Hemodynamics
(drug effects)
- In Vitro Techniques
- Male
- Myocardial Contraction
(drug effects)
- Myocardial Reperfusion
- Myocardium
(metabolism)
- Peptide Fragments
(administration & dosage, biosynthesis, genetics)
- RNA, Messenger
(metabolism)
- Rabbits
- Recombinant Proteins
- Treatment Outcome
- Ventricular Dysfunction
(etiology, prevention & control)
- Ventricular Function, Left
(drug effects)
- beta-Adrenergic Receptor Kinases
|